Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             126 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A case-control study of lung cancer at a dye and resin manufacturing plant 1993
 10 3-4 p. 266-
1 p.
 artikel
2 Action of a CD24-specific deglycosylated ricin-A-chain immunotoxin in conventional and novel models of small-cell-lung-cancer xenograft 1993
 10 3-4 p. 270-
1 p.
 artikel
3 Activity enhancement of a lung cancer-associated human monoclonal antibody HB4C5 by N-deglycosylation 1993
 10 3-4 p. 272-
1 p.
 artikel
4 Adjuvant chemotherapy after radical surgery for non-small-cell lung cancer: A randomized study 1993
 10 3-4 p. 284-285
2 p.
 artikel
5 Adjuvant chemotherapy with cyclophosphamide, doxorubicin, and cisplatin in patients with completely resected stage I non-small-cell lung cancer 1993
 10 3-4 p. 285-
1 p.
 artikel
6 Advanced non-small-cell lung cancer (NSCLC) treated with folinic acid (F), fluorouracil (FU), vincristine (O), and mitomycin-C (Mi), (F-FOMi) 1993
 10 3-4 p. 279-
1 p.
 artikel
7 Advances in lung cancer? 1993
 10 3-4 p. 285-
1 p.
 artikel
8 Allele diversity of the H-ras-1 variable number of tandem repeats in Norwegian lung cancer patients 1993
 10 3-4 p. 271-272
2 p.
 artikel
9 A meta-analysis of thoracic radiotherapy for small-cell lung cancer 1993
 10 3-4 p. 284-
1 p.
 artikel
10 An ACTH-secreting bronchial carcinoid: Presence of corticotropin-releasing hormone, neuropeptide Y and endothelin-1 in the tumor tissue 1993
 10 3-4 p. 277-
1 p.
 artikel
11 Analysis of early and late deaths on RTOG non-small cell carcinoma of the lung trials: comparison with CALGB 8433 Komaki, Ritsuko
 1993
 10 3-4 p. 189-197
9 p.
 artikel
12 Announcements Orel, J.
 1993
 10 3-4 p. 261-264
4 p.
 artikel
13 A novel 95 kilodalton membrane polypeptide associated with lung cancer drug resistance 1993
 10 3-4 p. 282-
1 p.
 artikel
14 A Phase II clinical trial evaluating the use of two sequential, four-drug combination chemotherapy regimens in ambulatory bronchogenic adenocarcinoma patients 1993
 10 3-4 p. 279-
1 p.
 artikel
15 A phase III comparison of etoposide/cisplatin with or without added ifosfamide in small-cell lung cancer 1993
 10 3-4 p. 279-280
2 p.
 artikel
16 A phase II study of high-dose epirubicin plus cisplatinum in advanced non-small-cell lung cancer (NSCLC) 1993
 10 3-4 p. 279-
1 p.
 artikel
17 A phase II study of ifosfamide in combination with etoposide and cisplatin in the treatment of extensive small cell lung cancer 1993
 10 3-4 p. 281-
1 p.
 artikel
18 Application of an algorithm for staging small-cell lung cancer can save one third of the initial evaluation costs 1993
 10 3-4 p. 274-275
2 p.
 artikel
19 A prospective study of cigarette tar yield and lung cancer 1993
 10 3-4 p. 268-
1 p.
 artikel
20 A randomized study comparing cyclophosphamide, doxorubicin, vincristine (CAV) with cyclophosphamide, etoposide, vincristine, methotrexate (CEVM) in patients with small cell lung cancer 1993
 10 3-4 p. 277-
1 p.
 artikel
21 Bronchogenic carcinoma in young patients at risk for acquired immunodeficiency syndrome 1993
 10 3-4 p. 277-
1 p.
 artikel
22 Bronchoplasty versus carinoplasty: The oncological value of two methods 1993
 10 3-4 p. 278-
1 p.
 artikel
23 Can we predict very short term survival in small cell lung cancer? Quoix, E.
 1993
 10 3-4 p. 229-238
10 p.
 artikel
24 Cardiac tamponade caused by primary lung cancer and the management of pericardial effusion 1993
 10 3-4 p. 273-274
2 p.
 artikel
25 Chemoprevention strategies in lung carcinogenesis 1993
 10 3-4 p. 266-
1 p.
 artikel
26 Chemotherapy-inducedanemia in patients with primary lung cancer 1993
 10 3-4 p. 279-
1 p.
 artikel
27 Clinical manifestations of lung cancer 1993
 10 3-4 p. 276-
1 p.
 artikel
28 Clinical usefulness of serum assays of neuron-specific enolase, carcinoembryonic antigen and CA-50 antigen in the diagnosis of lung cancer 1993
 10 3-4 p. 273-
1 p.
 artikel
29 Cloning and characterization of a Lambert-Eaton myasthenic syndrome antigen 1993
 10 3-4 p. 273-
1 p.
 artikel
30 Combination chemotherapy with ifosfamide and nimustine (IMA) as salvage treatment for small cell lung cancer 1993
 10 3-4 p. 283-
1 p.
 artikel
31 Comparison between two dosages of cisplatinum and etoposide in relapsing small cell lung carcinoma 1993
 10 3-4 p. 280-
1 p.
 artikel
32 Comparison of cisplatin plus vindesine with cisplatin plus mitomycin C for treatment of advanced non-small-cell lung cancer 1993
 10 3-4 p. 281-
1 p.
 artikel
33 Consolidative thoracic radiotherapy and prophylactic cranial irradiation in limited disease small cell lung cancer Slotman, B.J.
 1993
 10 3-4 p. 199-208
10 p.
 artikel
34 CPT-11 in combination with cisplatin for advanced non-small-cell lung cancer 1993
 10 3-4 p. 282-
1 p.
 artikel
35 Cytochrome P450HE1 genetic polymorphisms, racial variation, and lung cancer risk 1993
 10 3-4 p. 267-
1 p.
 artikel
36 Cytogenetic abnormalities in non-small cell lung carcinoma: Similarity of findings in conventional and feeder cell layer cultures 1993
 10 3-4 p. 270-
1 p.
 artikel
37 Cytokeratins expressed in experimental rat bronchial carcinomas 1993
 10 3-4 p. 270-
1 p.
 artikel
38 Detection of ras gene mutations in human lung cancer: Comparison of two screening assays based on the polymerase chain reaction Husgafvel-Pursiainen K, Ridanpaa M, Hackman P, Anttila S, Karjalainen A, Onfelt A et al. Institute of Occupational Health, Topeliuksenkatu 41 aA, SF-00250 Helsinki. Environ Health Perspect 1992;98:183–185 1993
 10 3-4 p. 271-
1 p.
 artikel
39 Development of new therapeutic strategies for mesothelioma 1993
 10 3-4 p. 285-286
2 p.
 artikel
40 Diagnostic tests for lung cancer 1993
 10 3-4 p. 276-
1 p.
 artikel
41 Differential cytotoxicity of 19 anticancer agents in wild type and etoposide resistant small cell lung cancer cell lines 1993
 10 3-4 p. 282-
1 p.
 artikel
42 Distinction of two different classes of small-cell lung cancer cell lines by enzymatically inactive neuron-specific enolase 1993
 10 3-4 p. 269-
1 p.
 artikel
43 dlk, A putative mammalian homeotic gene differentially expressed in small cell lung carcinoma and neuroendocrine tumor cell line 1993
 10 3-4 p. 272-
1 p.
 artikel
44 Dose intensity of initial chemotherapy may have an impact on survival in limited small cell lung carcinoma 1993
 10 3-4 p. 284-
1 p.
 artikel
45 Effect of novobiocin on cisplatin cytotoxicity and DNA interstrand cross-link formation in a cisplatin-resistant, small-cell lung carcinoma cell line 1993
 10 3-4 p. 280-
1 p.
 artikel
46 Effect of occupational air pollutants on various histological types of lung cancer: A population based case-control study 1993
 10 3-4 p. 268-
1 p.
 artikel
47 Elevated uptake of low density lipoproteins by human lung cancer tissue in vivo 1993
 10 3-4 p. 269-
1 p.
 artikel
48 Epidermoid carcinoma of the lung in stage I: Factors of prognostic interest 1993
 10 3-4 p. 274-
1 p.
 artikel
49 Etoposide versus methotrexate in small cell bronchial carcinoma: A randomized study of two types of four-drug chemotherapy regimens 1993
 10 3-4 p. 284-
1 p.
 artikel
50 Exercise testing, 6-min walk, and stair climb in the evaluation of patients at high risk for pulmonary resection 1993
 10 3-4 p. 277-278
2 p.
 artikel
51 Expression of functional PDGF β receptors in a human large-cell lung-carcinoma cell line 1993
 10 3-4 p. 272-
1 p.
 artikel
52 Expression of the proto-oncogenes c-met and c-kit and their ligands, hepatocyte growth factor/scatter factor and stem cell factor, in SCLC cell lines and xenografts 1993
 10 3-4 p. 270-
1 p.
 artikel
53 Extensive small-cell lung cancer. A randomized comparison of two chemotherapy programs with early crossover in instances of failure 1993
 10 3-4 p. 279-
1 p.
 artikel
54 Final evaluation of a phase II study on the effect of edelfosine (an ether lipid) in advanced non-small-cell bronchogenic carcinoma 1993
 10 3-4 p. 280-281
2 p.
 artikel
55 Genotype and phenotype of glutathione S-transferase class isoenzymes and psi in lung cancer patients and controls 1993
 10 3-4 p. 273-
1 p.
 artikel
56 Granulocyte colony-stimulating factor in lung cancer 1993
 10 3-4 p. 275-
1 p.
 artikel
57 Hypofractionated radiation therapy in the treatment of superior vena cava syndrome Rodrigues, C.I.
 1993
 10 3-4 p. 221-228
8 p.
 artikel
58 IASLC calendar 1993
 10 3-4 p. 265-
1 p.
 artikel
59 Immunohistochemical study of glutathione-related enzymes and proliferative antigens in lung cancer: Relation to cisplatin sensitivity 1993
 10 3-4 p. 272-273
2 p.
 artikel
60 Incidence of lung cancer by histological type among asbestos cement workers in Denmark 1993
 10 3-4 p. 267-
1 p.
 artikel
61 Induction chemotherapy with MVP (mitomycin-C + vindesine + cisplatin) for stage III (T1-3, N2, M0) unresectable non-small cell lung cancer: The Toronto experience 1993
 10 3-4 p. 283-
1 p.
 artikel
62 Interleukin-2 activity in patients with extensive small-cell lung cancer: A phase II trial of cancer and leukemia group B 1993
 10 3-4 p. 283-
1 p.
 artikel
63 In vitro effect of suramin on lung tumour cells 1993
 10 3-4 p. 278-
1 p.
 artikel
64 K-ras mutations in human adenocarcinoma of the lung: Association with smoking and occupational exposure to asbestos 1993
 10 3-4 p. 267-268
2 p.
 artikel
65 Lambert-Eaton syndrome and small cell lung cancer 1993
 10 3-4 p. 275-
1 p.
 artikel
66 Low p53 protein expression in salivary gland tumours compared with lung carcinomas 1993
 10 3-4 p. 269-
1 p.
 artikel
67 Lung cancer cell lines as model systems for studying drug resistance 1993
 10 3-4 p. 282-
1 p.
 artikel
68 Lung cancer in patients with immunodeficiency syndrome 1993
 10 3-4 p. 276-
1 p.
 artikel
69 Lung cancer mortality among a cohort of male chromate pigment workers in Japan 1993
 10 3-4 p. 268-269
2 p.
 artikel
70 Lung cancer: Worldwide variation in occurrence and proportion attributable to tobacco use 1993
 10 3-4 p. 268-
1 p.
 artikel
71 Metastatic spinal cord compression secondary to lung cancer 1993
 10 3-4 p. 275-
1 p.
 artikel
72 Migration to towns, occupation, smoking, and lung cancer: Experience from the Finnish-Norwegian lung cancer study 1993
 10 3-4 p. 268-
1 p.
 artikel
73 Mutational analysis of a dominant oncogene (c-Ki-ras-2) and a tumor suppressor gene (p53) in hamster lung tumorigenesis 1993
 10 3-4 p. 267-
1 p.
 artikel
74 Neuroendocrine differentiation as a prognostic factor in non-small cell lung cancer Carles, J.
 1993
 10 3-4 p. 209-219
11 p.
 artikel
75 N-methylcarbamate derivatives of ellipticine and olivacine with cytotoxic activity against four human lung cancer cell lines 1993
 10 3-4 p. 269-
1 p.
 artikel
76 No effect of an antiaggregant treatment with aspirin in small cell lung cancer treated with CCAVP16 chemotherapy: Results from a randomized clinical trial of 303 patients 1993
 10 3-4 p. 283-
1 p.
 artikel
77 Nonspecific crossreacting antigen (NCA) is a major member of the carcinoembryonic antigen (CEA)-related gene family expressed in lung cancer 1993
 10 3-4 p. 269-270
2 p.
 artikel
78 Occupational lung cancer 1993
 10 3-4 p. 266-
1 p.
 artikel
79 Occupation and lung cancer risk in Trieste, Italy 1993
 10 3-4 p. 267-
1 p.
 artikel
80 Pancoast syndrome: An unusual presentation of adenoid cystic carcinoma 1993
 10 3-4 p. 277-
1 p.
 artikel
81 Pancoast tumor: Use of MRI for tumor staging 1993
 10 3-4 p. 273-
1 p.
 artikel
82 Paraneoplastic syndromes associated with lung cancer 1993
 10 3-4 p. 276-
1 p.
 artikel
83 Partial suppression of tumorigenicity in a human lung cancer cell line transfected with Krev-1 1993
 10 3-4 p. 269-
1 p.
 artikel
84 Patient compliance with prolonged low-dose oral etoposide for small cell lung cancer 1993
 10 3-4 p. 284-
1 p.
 artikel
85 Patient progress modelling for small cell lung cancer 1993
 10 3-4 p. 277-
1 p.
 artikel
86 PCR-based CYP2D6 genotyping for Finnish lung cancer patients 1993
 10 3-4 p. 272-
1 p.
 artikel
87 Pharmacokinetics of 10-ethyl-10-deaza-aminopterin, edatrexate, given weekly for non-small-cell lung cancer 1993
 10 3-4 p. 280-
1 p.
 artikel
88 Phase II study of cisplatin, ifosfamide, and etoposide combination for advanced non-small cell lung cancer: Final report 1993
 10 3-4 p. 281-
1 p.
 artikel
89 Phase II trial of trimetrexate for unresectable or metastatic non-small cell bronchogenic carcinoma 1993
 10 3-4 p. 280-
1 p.
 artikel
90 Photodynamic therapy (PDT) in early stage lung cancer 1993
 10 3-4 p. 285-
1 p.
 artikel
91 Platin-vindesin-ametycin-bleomycin regimen in stage IV non small cell lung cancer 1993
 10 3-4 p. 281-
1 p.
 artikel
92 Preoperative laser therapy in a patient with resectable bronchogenic carcinoma and severe coronary artery disease 1993
 10 3-4 p. 285-
1 p.
 artikel
93 Primary chemotherapy in stage IIIA non-small cell lung cancer patients with clinically apparent mediastinal lymph node metastases: Focus on five-year survivors 1993
 10 3-4 p. 282-283
2 p.
 artikel
94 Prognostic value of neuron-specific enolase in small cell lung cancer patients 1993
 10 3-4 p. 274-
1 p.
 artikel
95 Protein turnover in advanced lung cancer patients 1993
 10 3-4 p. 276-277
2 p.
 artikel
96 Quality of life assessment in individuals with lung cancer: Testing the lung cancer symptom scale (LCSS) 1993
 10 3-4 p. 274-
1 p.
 artikel
97 Radical laser segmentectomy for T1 N0 lung cancer 1993
 10 3-4 p. 285-
1 p.
 artikel
98 Rapallo Conference: New Frontiers in Lung Cancer Motta, Giovanni
 1993
 10 3-4 p. 257-260
4 p.
 artikel
99 ras Oncogene activation and the expression of ras-related genes in human lung cancer 1993
 10 3-4 p. 271-
1 p.
 artikel
100 Recombination human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for non-small cell lung cancer 1993
 10 3-4 p. 283-284
2 p.
 artikel
101 Regional lung cancer death rates unrelated to smoking? The case of The Netherlands 1993
 10 3-4 p. 266-267
2 p.
 artikel
102 Relationship of H-ras-1, L-myc, and p53 polymorphisms with lung cancer risk and prognosis 1993
 10 3-4 p. 271-
1 p.
 artikel
103 Respiratory failure due to pulmonary lymphangitis carcinomatosis 1993
 10 3-4 p. 284-
1 p.
 artikel
104 Risk factors for lung cancer among nonsmoking Illinois residents 1993
 10 3-4 p. 266-
1 p.
 artikel
105 Second lung cancer following radiation therapy of locally advanced pulmonary cancer Furuta, Masaya
 1993
 10 3-4 p. 251-255
5 p.
 artikel
106 Second primary malignancies following diagnosis of small-cell lung cancer 1993
 10 3-4 p. 286-
1 p.
 artikel
107 Serum fragment of cytokeratin subunit 19 measured by CYFRA 21-1 immunoradiometric assay as a marker of lung cancer 1993
 10 3-4 p. 274-
1 p.
 artikel
108 Serum tumor markers CEA, CA 50, TATI, and NSE in lung cancer screening 1993
 10 3-4 p. 276-
1 p.
 artikel
109 Somatostatin and the lung O'Byrne, K.J.
 1993
 10 3-4 p. 151-172
22 p.
 artikel
110 Spontaneous pneumothorax as initial symptom of bronchial carcinoma 1993
 10 3-4 p. 277-
1 p.
 artikel
111 Superior vena cava syndrome in small-cell lung cancer 1993
 10 3-4 p. 275-
1 p.
 artikel
112 Teniposide for meningeal carcinomatosis of small cell lung cancer van der Graaf, Winette T.A.
 1993
 10 3-4 p. 247-249
3 p.
 artikel
113 Testing the possible non-cross resistance of two equipotent combination chemotherapy regimens against small-cell lung cancer: A phase II study of the EORTC Lung Cancer Cooperative Group 1993
 10 3-4 p. 278-
1 p.
 artikel
114 The combination of mitomycin, vinblastine and cisplatin is active in the palliation of stage IIIB-IV non-small-cell lung cancer 1993
 10 3-4 p. 281-
1 p.
 artikel
115 The debrisoquine metabolic phenotype and DNA-based assays: Implications of misclassification for the association of lung cancer and the debrisoquine metabolic phenotype 1993
 10 3-4 p. 271-
1 p.
 artikel
116 The incidence of second primary tumors in long-term survivors of small-cell lung cancer 1993
 10 3-4 p. 286-
1 p.
 artikel
117 The prognostic significance of bone marrow metastases in small cell lung cancer patients Zych, Jacek
 1993
 10 3-4 p. 239-245
7 p.
 artikel
118 The role of mediastinoscopic biopsy in preoperative assessment of lung cancer 1993
 10 3-4 p. 273-
1 p.
 artikel
119 The use of granulocyte colony-stimulating factor to shorten the interval between cycles of mitomycin C, vindesine, and cisplatin chemotherapy in non-small-cell lung cancer 1993
 10 3-4 p. 278-
1 p.
 artikel
120 Thrombosis of the IVC and azygous continuation of IVC by bronchogenic cancer: CT and MRI appearance 1993
 10 3-4 p. 273-
1 p.
 artikel
121 Tracheobronchial resection for tumor: Classification and related biological problems 1993
 10 3-4 p. 278-
1 p.
 artikel
122 Treatment of advanced non-small cell lung cancer with very high-dose cisplatin combined with etoposide and mitomycin C 1993
 10 3-4 p. 282-
1 p.
 artikel
123 Treatment of non-small cell lung cancer: new cytostatic agents Sorensen, Jens Benn
 1993
 10 3-4 p. 173-187
15 p.
 artikel
124 Tumor-suppressive effect of the retinoic acid receptor β in human epidermoid lung cancer cells 1993
 10 3-4 p. 270-271
2 p.
 artikel
125 Video-assisted thoracic surgical resection of malignant lung tumors 1993
 10 3-4 p. 278-
1 p.
 artikel
126 Women with lung cancer: Impact on quality of life 1993
 10 3-4 p. 275-276
2 p.
 artikel
                             126 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland